Aethlon Medical, Inc.
Aethlon Medical, Inc.（AEMD）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AEMD · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Aethlon Medical, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AEMD 季度内部人买卖趋势
AEMD 内幕交易卖出 · AEMD 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AEMD CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AEMD 高管卖出股份 · AEMD 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 17, 2026 | Rossetti Angela Director | Award | 21,815 | $50K | Form 4 |
| Apr 17, 2026 | Shah Chetan Director | Award | 21,815 | $50K | Form 4 |
| Apr 17, 2026 | BROENNIMAN EDWARD G Director | Award | 21,815 | $50K | Form 4 |
| Apr 17, 2026 | Gikakis Nicolas Director | Award | 21,815 | $50K | Form 4 |
| Mar 31, 2026 | Shah Chetan Director | Other | 178 | $390 | Form 4 |
| Mar 31, 2026 | Gikakis Nicolas Director | Other | 178 | $390 | Form 4 |
| Mar 31, 2026 | BROENNIMAN EDWARD G Director | Other | 89 | $195 | Form 4 |
| Dec 31, 2025 | Shah Chetan Director | Other | 179 | $496 | Form 4 |
| Dec 31, 2025 | Gikakis Nicolas Director | Other | 179 | $496 | Form 4 |
| Dec 31, 2025 | BROENNIMAN EDWARD G Director | Other | 89 | $247 | Form 4 |
| Sep 30, 2025 | Shah Chetan Director | Other | 1,786 | $1K | Form 4 |
| Sep 30, 2025 | Gikakis Nicolas Director | Other | 1,786 | $1K | Form 4 |
| Sep 30, 2025 | BROENNIMAN EDWARD G Director | Other | 893 | $669 | Form 4 |
| Jun 30, 2025 | BROENNIMAN EDWARD G Director | Other | 893 | $1K | Form 4 |
| Jun 30, 2025 | Gikakis Nicolas Director | Other | 1,786 | $2K | Form 4 |
| Jun 30, 2025 | Shah Chetan Director | Other | 1,786 | $2K | Form 4 |
| Apr 23, 2025 | Gikakis Nicolas Director | Award | 142,857 | $50K | Form 4 |
| Apr 23, 2025 | Rossetti Angela Director | Award | 142,857 | $50K | Form 4 |
| Apr 23, 2025 | BROENNIMAN EDWARD G Director | Award | 142,857 | $50K | Form 4 |
| Apr 23, 2025 | Shah Chetan Director | Award | 142,857 | $51K | Form 4 |
| Mar 31, 2025 | BROENNIMAN EDWARD G Director | Other | 1,645 | $589 | Form 4 |
| Mar 31, 2025 | Shah Chetan Director | Other | 3,289 | $1K | Form 4 |
| Mar 31, 2025 | Gikakis Nicolas Director | Other | 3,289 | $1K | Form 4 |
| Dec 31, 2024 | BROENNIMAN EDWARD G Director | Other | 1,645 | $1K | Form 4 |
| Dec 31, 2024 | Shah Chetan Director | Other | 3,289 | $3K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AEMD 内幕交易
AEMD 内幕交易
Aethlon Medical, Inc.（AEMD）内幕交易数据来源于公司内部人（包括Shah Chetan (Director), BROENNIMAN EDWARD G (Director), Gikakis Nicolas (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。AEMD内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Aethlon Medical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AEMD 内幕交易 · 5个问题Aethlon Medical, Inc.（AEMD）的内部人包括高管和董事，如Shah Chetan (Director), BROENNIMAN EDWARD G (Director), Gikakis Nicolas (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026